美国医疗低温运输包装市场规模、份额和趋势分析报告：按产品、包装类型、温度要求、应用和细分市场预测，2026-2033年

市场规模与趋势：

据估计，2025年美国医疗低温运输包装市值为37.2亿美元，预计2033年将达到93.2亿美元。

预计从 2026 年到 2033 年，该行业将以 12.2% 的复合年增长率增长，这主要得益于对温度敏感的药品（尤其是生物製药、疫苗、细胞和基因疗法以及高度专业化的药物）的开发和分销不断增加。

这些产品在储存和运输过程中通常需要精确的温度控制，以保持其功效和效力。例如，mRNA疫苗和许多单株抗体即使在温度发生微小波动时也会失去效力，因此高性能的隔热包装和超低温解决方案至关重要。

随着製药公司不断将重点从传统小分子药物转向生物製药和个人化医疗，它们对可靠的低温运输包装的依赖也迅速增强。在美国医疗保健市场，受製药创新、医疗服务模式、法律规范以及供应链风险管理等方面的结构性变革的推动，对低温运输包装的需求正在稳步增长。过去，低温运输要求仅限于少数疫苗和生物製药，而如今，温度控制已成为涵盖广泛且不断增长的医疗产品领域的基本要求。

推动市场成长的关键因素之一是温度敏感型药品（尤其是生物製药、特药、疫苗以及细胞和基因疗法等先进治疗方法）的快速成长。这些产品在狭窄的温度范围之外极不稳定，即使短暂暴露于温度变化中，也可能失去效力或失效。随着美国药物开发平臺生物製药产品而非传统小分子药物的比例不断上升，需要冷藏、冷冻和超低温保存的产品数量也显着增加。因此，製药公司正大力投资检验的低温运输包装解决方案，以确保产品在长距离运输和复杂的通路中保持热稳定性。

与此趋势密切相关的是美国生物製药研究、临床试验和商业化的强劲成长。美国承担全球大部分临床试验，其中许多试验涉及在严格的温度控制下，将临床实验药物从製造地运送到测试机构、实验室和储存设施。这些运输涉及长途跋涉和多次交接，增加了温度波动的风险。因此，对高性能隔热包装、相变材料和经认证的运输系统的需求日益增长，这些系统能够在整个研究週期中保持温度的稳定性。

目录

第一章调查方法和范围

第二章执行摘要

3. 美国医疗低温运输包装市场变数、趋势与范围

• 市场谱系展望
• 产业价值链分析
• 技术概述
• 供需差距分析（2025 年）
• 永续性趋势
• 法律规范
• 市场动态
• 商业环境分析
  • 波特五力分析
  • PESTEL 分析

第四章：美国医疗低温运输包装市场：按产品分類的估价与趋势分析

• 产品特定波动分析及市场份额（2025 年和 2033 年）
  • 保温托盘运输
  • 保温容器
  • 真空绝热板
  • 冷却包和冷媒
  • 标籤感测器
  • 其他的

第五章 美国医疗低温运输包装市场：按包装类型分類的估价与趋势分析

• 按包装形式和市场份额分類的变化分析（2025 年和 2033 年）
  • 积极的
  • 被动的

第六章：美国医疗低温运输包装市场：依温度要求分類的估价与趋势分析

• 按温度需求分類的变化分析和市场份额（2025 年和 2033 年）
  • 室温控制（CRT）
  • 冷藏（2 ℃至8 ℃）
  • 冷冻（-20 度C至 -40 度C）
  • 低温（低于-80 度C）

第七章：美国医疗低温运输包装市场：按应用分類的估价与趋势分析

• 按应用领域分類的趋势分析和市场份额（2025 年和 2033 年）
  • 生物製药公司
  • 临床研究所
  • 医院和医疗保健机构
  • 研究机构和实验室
  • 物流/配送公司
  • 其他的

第八章 竞争情势

• 主要企业和近期趋势及其对该行业的影响
• 供应商概况
  • 公司分类
  • 潜在原料供应商和通路伙伴名单
• 竞争动态
  • 市占率分析
  • 企业市场分析
  • 策略规划

第九章 公司列表（概述、财务表现、产品概述）

• Sealed Air Corporation
• Peli BioThermal LLC
• CSafe
• DGP Intelsius LLC
• ThermoSafe Technologies Inc.
• Cryoport Systems, LLC

Market Size & Trends:

The U.S. healthcare cold chain packaging market size was estimated at USD 3.72 billion in 2025 and is projected to reach USD 9.32 billion by 2033, growing at a CAGR of 12.2% from 2026 to 2033. This is attributed to the increasing development and distribution of temperature-sensitive drugs, especially biologics, vaccines, cell and gene therapies, and advanced specialty medicines.

These products often require precise thermal conditions throughout storage and transportation to retain potency and efficacy. For example, mRNA-based vaccines and many monoclonal antibodies lose effectiveness if exposed to even minor temperature variations, necessitating high-performance insulated packaging and ultracold solutions.

As pharmaceutical companies continue to shift focus from traditional small-molecule drugs toward biologics and personalized medicines, the reliance on robust cold chain packaging has surged. The demand for cold chain packaging in the U.S. healthcare market is expanding steadily, driven by structural shifts in pharmaceutical innovation, healthcare delivery models, regulatory oversight, and supply-chain risk management. Unlike earlier periods when cold chain requirements were limited to a narrow set of vaccines and biologics, temperature control has now become a foundational requirement across a broad and growing segment of healthcare products.

A primary factor driving the growth is the rapid increase in temperature-sensitive pharmaceuticals, particularly biologics, specialty drugs, vaccines, and advanced therapies such as cell and gene treatments. These products are inherently unstable outside narrow temperature ranges and can lose potency or become unusable if exposed to even brief temperature excursions. The U.S. pharmaceutical pipeline is increasingly dominated by biologics rather than traditional small-molecule drugs, which significantly raises the volume of products requiring refrigerated, frozen, or ultra-cold conditions. As a result, pharmaceutical manufacturers are investing heavily in validated cold chain packaging solutions that can ensure thermal stability across long and complex distribution routes.

Closely linked to this trend is the strong growth in biopharmaceutical research, clinical trials, and commercialization activity within the U.S. The country hosts a large share of global clinical trials, many of which involve investigational drugs that must be transported between manufacturing sites, trial centers, laboratories, and storage facilities under strict temperature controls. These shipments often span long distances and multiple handovers, increasing the risk of temperature deviation. Consequently, demand is rising for high-performance insulated packaging, phase-change materials, and qualified shipping systems that can maintain temperature integrity throughout the trial lifecycle.

U.S. Healthcare Cold Chain Packaging Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare cold chain packaging market report based on product, temperature requirement, packaging format, and application:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Insulated Pallet Shippers
• Insulated Containers
• Vacuum Insulated Panels
• Cold Packs & Refrigerants
• Labels & Sensors
• Others
• Temperature Requirement Outlook (Revenue, USD Million, 2021 - 2033)
• Controlled Room Temperature (CRT)
• Refrigerated (2°C-8°C)
• Frozen (-20°C to -40°C)
• Cryogenic (<-80°C)
• Packaging Format Outlook (Revenue, USD Million, 2021 - 2033)
• Active
• Passive
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Companies
• Clinical Research Organizations
• Hospitals and Healthcare Providers
• Research Institutes & Labs
• Logistics and Distribution Companies
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Research Methodology
  • 1.1.1. Market Segmentation
  • 1.1.2. Market Definition
• 1.2. Research Scope & Assumptions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing
• 1.7. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot, (USD Million)
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Healthcare Cold Chain Packaging Market Variables, Trends, and Scope

• 3.1. Market Lineage Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Technology Overview
• 3.4. Supply Demand Gap Analysis, 2025
• 3.5. Sustainability Trends
• 3.6. Regulatory Framework
• 3.7. Market Dynamics
  • 3.7.1. Market Driver Analysis
  • 3.7.2. Market Restraint Analysis
  • 3.7.3. Market Challenge Analysis
• 3.8. Business Environment Analysis
  • 3.8.1. Porter's Five Forces Analysis
  • 3.8.2. PESTEL Analysis

Chapter 4. U.S. Healthcare Cold Chain Packaging Market: Product Estimates & Trend Analysis

• 4.1. Key Takeaways
• 4.2. Product Movement Analysis & Market Share, 2025 & 2033
  • 4.2.1. Insulated Pallet Shippers
    • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.2. Insulated Containers
    • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.3. Vacuum Insulated Panels
    • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.4. Cold Packs & Refrigerants
    • 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.5. Labels & Sensors
    • 4.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.6. Others
    • 4.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Healthcare Cold Chain Packaging Market: Packaging Format Estimates & Trend Analysis

• 5.1. Key Takeaways
• 5.2. Packaging Format Movement Analysis & Market Share, 2025 & 2033
  • 5.2.1. Active
    • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.2.2. Passive
    • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Healthcare Cold Chain Packaging Market: Temperature Requirement Format Estimates & Trend Analysis

• 6.1. Key Takeaways
• 6.2. Temperature Requirement Movement Analysis & Market Share, 2025 & 2033
  • 6.2.1. Controlled Room Temperature (CRT)
    • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.2. Refrigerated (2°C-8°C)
    • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.3. Frozen (-20°C to -40°C)
    • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.4. Cryogenic (<-80°C)
    • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Healthcare Cold Chain Packaging Market: Application Format Estimates & Trend Analysis

• 7.1. Key Takeaways
• 7.2. Application Movement Analysis & Market Share, 2025 & 2033
  • 7.2.1. Biopharmaceutical Companies
    • 7.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.2. Clinical Research Organizations
    • 7.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.3. Hospitals and Healthcare Providers
    • 7.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.4. Research Institutes & Labs
    • 7.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.5. Logistics and Distribution Companies
    • 7.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.6. Others
    • 7.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Key Players & Recent Developments & Their Impact on the Industry
• 8.2. Vendor Landscape
  • 8.2.1. Company Categorization
  • 8.2.2. List of Potential Raw Material Suppliers & Channel Partners
• 8.3. Competitive Dynamics
  • 8.3.1. Market Share Analysis
  • 8.3.2. Company Market Position Analysis
  • 8.3.3. Strategy Mapping
    • 8.3.3.1. Expansions
    • 8.3.3.2. Mergers & Acquisitions
    • 8.3.3.3. Collaborations
    • 8.3.3.4. New Product Launches
    • 8.3.3.5. Others

Chapter 9. Company Listing (Overview, Financial Performance, Product Overview)

• 9.1. Sealed Air Corporation
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
• 9.2. Peli BioThermal LLC
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
• 9.3. CSafe
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
• 9.4. DGP Intelsius LLC
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
• 9.5. ThermoSafe Technologies Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
• 9.6. Cryoport Systems, LLC
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking

List of Tables

• Table 1 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Product, 2021 - 2033 (USD Million)
• Table 2 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Packaging Format, 2021 - 2033 (USD Million
• Table 3 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Temperature Requirement, 2021 - 2033 (USD Million)
• Table 4 U.S. Healthcare Cold Chain Packaging Market Revenue Estimates and Forecasts, By Application, 2021 - 2033 (USD Million)
• Table 5 Recent Developments & Impact Analysis, By Key Market Participants

List of Figures

• Fig. 1 Market Segmentation & Scope
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Research Process
• Fig. 5 Market Research Approaches - Bottom-Up Approach
• Fig. 6 Market Research Approaches - Top-Down Approach
• Fig. 7 Market Research Approaches - Combined Approach
• Fig. 8 U.S. Healthcare Cold Chain Packaging Market: Market Insights (USD Million)
• Fig. 9 U.S. Healthcare Cold Chain Packaging Market: Segmental Insights (USD Million) (1/2)
• Fig. 10 U.S. Healthcare Cold Chain Packaging Market: Segmental Insights (USD Million) (2/2)
• Fig. 11 U.S. Healthcare Cold Chain Packaging Market: Competitive Outlook
• Fig. 12 U.S. Healthcare Cold Chain Packaging Market: Industry Value Chain Analysis
• Fig. 13 Market Dynamics
• Fig. 14 Median Age, 2000 - 2030 (Years)
• Fig. 15 U.S. Healthcare Cold Chain Packaging Market: Porter's Five Forces Analysis
• Fig. 16 U.S. Healthcare Cold Chain Packaging Market: PESTEL Analysis
• Fig. 17 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 18 U.S. Healthcare Cold Chain Packaging Market, By Product: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 19 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Insulated Pallet Shippers, 2021 - 2033 (USD Million)
• Fig. 20 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Insulated Containers, 2021 - 2033 (USD Million)
• Fig. 21 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Vacuum Insulated Panels, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Cold Packs & Refrigerants, 2021 - 2033 (USD Million)
• Fig. 23 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Labels & Sensors, 2021 - 2033 (USD Million)
• Fig. 24 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Other Products, 2021 - 2033 (USD Million)
• Fig. 25 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 26 U.S. Healthcare Cold Chain Packaging Market, By Packaging Format: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 27 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Passive Packaging, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Active Packaging, 2021 - 2033 (USD Million)
• Fig. 29 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 30 U.S. Healthcare Cold Chain Packaging Market, By Temperature Requirement: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 31 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Controlled Room Temperature (CRT), 2021 - 2033 (USD Million)
• Fig. 32 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Refrigerated (2°C-8°C), 2021 - 2033 (USD Million)
• Fig. 33 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Frozen (-20°C to -40°C), 2021 - 2033 (USD Million)
• Fig. 34 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, By Cryogenic (<-80°C), 2021 - 2033 (USD Million)
• Fig. 35 U.S. Healthcare Cold Chain Packaging Market: Key Takeaways
• Fig. 36 U.S. Healthcare Cold Chain Packaging Market, By Application: Market Share, By Revenue, 2025 & 2033 (%)
• Fig. 37 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Biopharmaceutical Companies, 2021 - 2033 (USD Million)
• Fig. 38 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Clinical Research Organizations, 2021 - 2033 (USD Million)
• Fig. 39 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Hospitals and Healthcare Providers, 2021 - 2033 (USD Million)
• Fig. 40 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Research Institutes & Labs, 2021 - 2033 (USD Million)
• Fig. 41 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Logistics and Distribution Companies, 2021 - 2033 (USD Million)
• Fig. 42 U.S. Healthcare Cold Chain Packaging Market Estimates & Forecasts, For Other Applications, 2021 - 2033 (USD Million)
• Fig. 43 U.S. Healthcare Cold Chain Packaging Market: Company Market Share Analysis, 2025
• Fig. 44 U.S. Healthcare Cold Chain Packaging Market: Competitive Benchmarking
• Fig. 45 Strategy Mapping